Since June 3, 2020, DiaSys is part of the IFCC Task Force on COVID-19.
The major objectives of this Task Force include regular provision of up-to-date information on epidemiology, pathogenesis and laboratory diagnostics of COVID-19. Furthermore, practical recommendations to harmonize the use of diagnostic tests for COVID-19 as well as biosafety measures for sample handling will be developed. In addition, international studies will be organized to improve the knowledge on pathogenesis, diagnostics and therapeutic handling of COVID-19.
In addition to the extensive product portfolio for the companion diagnostics of COVID-19, DiaSys makes another important contribution to the active containment and combat of the coronavirus.
Exhibitor Data Sheet